Pablo Velasco Puyó I have been an medical physician in the Pediatric Oncology and Hematology Service since 2012. My medical and research activity focuses primarily on sickle cell disease and pediatric acute lymphoblastic leukemia. Instituciones de las que forman parte Investigador predoctoral Cáncer y Enfermedades Hematológicas Infantiles Vall Hebron Institut de Recerca Médico Oncología y Hematología Pediátrica Hospital Infantil i Hospital de la Mujer Email Pablo Velasco Puyó Email Instituciones de las que forman parte Investigador predoctoral Cáncer y Enfermedades Hematológicas Infantiles Vall Hebron Institut de Recerca Médico Oncología y Hematología Pediátrica Hospital Infantil i Hospital de la Mujer I have been an medical physician in the Pediatric Oncology and Hematology Service since 2012. My medical and research activity focuses primarily on sickle cell disease and pediatric acute lymphoblastic leukemia.
During my professional career I have tried to develop a comprehensive care of these diseases, with the direct assistance of patients, as well as with clinical and translational research, including direct work in the laboratory, participation in 12 clinical trials as principal investigator or subinvestigator, and the publication of 17 scientific articles and 1 book chapter, related to these diseases. - At the teaching level I am an associate professor at the Faculty of Medicine of the Autonomous University of Barcelona, I have participated in national and international conferences (59 as an author), in pediatric hematology courses and together with doctors and nurses of the department, we have created the first oncohematological emergency simulations in situ. We have also created, together with pediatric hematologists from different centers, the Working Group on Pediatric Hematology of the Catalan Society of Pediatrics, which I currently co-coordinate. - In this difficult year of the COVID pandemic, concerned with understanding and adapting to the risk of our patients with SARS-CoV2, we have created the European COVID registry in the European reference network EurobloodNet, of which I am a principal investigator, and we have collaborated in the largest registry of pediatric oncology and COVID, the Global Registry of COVID-19 in Pediatric Cancer (StJude-SIOP). I am part of the national and international scientific groups SEHOP, SIOPE, Eurobloodnet, Spanish Cytology Club, SEHH, EHA - But for global care it is necessary to develop initiatives focused on patients and their families from other perspectives, so we invented with Eunice Blanco, head of Social Work the Superbox device (new medical device to facilitate patient-friendly intravenous administration, more information at www.superbox.es) and I have participated in the formation of the Spanish association of patients with sickle cell disease ASAFE, of which I am part of the board of the association (https://www.asafefalciforme.org/). Giving patients a voice is a very valuable tool for healthcare professionals, a compass to indicate the right path for our actions. - As a curiosity, I am also a veterinarian, it was during my training at L’Ecole Veterinaire de MAison Alfort in Paris, before year 2000, where I learned how much translational research between species can contribute to the understanding of oncology and the research of new treatments. - I have also worked as an expatriate pediatrician in several countries in Africa, Guatemala and India, and I have been trained in the international Red Cross emergency team, with the conviction that health care should be global and equitable for all children.
Proyectos TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas IP: Begoña Benito Villabriga Colaboradores: Carmen Escudero Iriarte, Laia Ventura i Expósito, Susana Otero Romero, Ignacio Ferreira González, José Antonio Barrabés Riu, Carlos Nos Llopis, Pablo Velasco Puyó, Jose Fernando Rodríguez Palomares, María Rosario Pérez- Torres Lobato, Sunny Malhotra Sareen, Belen Perez Dueñas, Jaume Sastre Garriga, Joan López Hellin, Antonia Sambola Ayala, Jordi Rio Izquierdo, Nuria Rivas Gandara, Jordi Perez Rodon, Aroa Soriano Fernández, Manuel Comabella Lopez, Antonio Rodríguez Sinovas, Gisela Teixido Tura, Antonia Pijuan Domenech, Roser Ferrer Costa, Joaquin Seras Franzoso, Carmen Tur Gomez, Maria Cristina Díaz de Heredia Rubio, Laia Yañez Bisbe, Julia German Cortes, Maria Jose Pérez García, Miguel Segura Ginard, Diego Baranda Martínez-Abasca, Cristina Auger Acosta, Neus Bellera Gotarda, Herena Eixarch Ahufinger, M Mar Mañu Pereira, Deborah Pareto Onghena, Lorena Valero Arrese, Aitor Uribarri Gonzalez, Jordi Bañeras Rius, Alex Rovira Cañellas, Mar Tintore Subirana, Bruno García del Blanco, Maria Teresa Salcedo Allende, Marisol Ruiz Meana, Ana Belén Méndez Fernández, Xavier Montalban Gairín, Simon Schwartz Navarro, Anna Llort Sales, Carmen Espejo Ruiz, Raquel Hladun Alvaro, Angels Alcina Mila, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Ana Zabalza de Torres, Marc Miquel Moltó Abad, Javier Inserte Igual, Luciana Midaglia Fernandez, Elizabeth Pando Rau, Gabriela Guillén Burrieza, Ana Laura Cazurro Gutierrez, David Gómez Andrés, Alvaro Cobo Calvo, Alvaro Calabuig Goena, Joaquin Castillo Justribo, Lydia Dux-Santoy Hurtado, Lucas Moreno Martín-Retortillo, Andres Miguez Gonzalez, Josep Roma Castanyer, Laura Dos Subirá, Nicolás Miguel Fissolo, Maria Nazarena Pizzi, Tian Tian, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Andrea Guala Entidad financiadora: Instituto de Salud Carlos III Financiación: 2494527.53 Referencia: FORT23/00034 Duración: 01/01/2024 - 31/12/2027 Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders IP: Lucas Moreno Martín-Retortillo Colaboradores: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Júlia Sansa Girona, Gabriela Guillén Burrieza, Laura Alonso Garcia, Victoria Gutierrez Valle, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Amira Idrizovic Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca Financiación: 60000 Referencia: 2021 SGR 00638 Duración: 01/01/2022 - 30/06/2025 ENABLING PERSONALIZED MEDICINE OF SICKLE CELL DISEASE PATIENTS BASED ON INTEGRATIVE DIAGNOSIS OF NEW GENERATION METHODOLOGIES IP: M Mar Mañu Pereira Colaboradores: Pablo Velasco Puyó, Bárbara Tazón Vega, Maria Cristina Díaz de Heredia Rubio, Thaïs Murciano Carrillo, Victoria Gutierrez Valle, Amira Idrizovic Entidad financiadora: Instituto de Salud Carlos III Financiación: 99220 Referencia: PI20/01454 Duración: 01/01/2021 - 30/06/2025 El papel oncogénico de las vías embrionarias (Notch, Hedgehog y Wnt) en el Rabdomiosarcoma: ampliando el conocimiento para descubrir nuevas dianas terapéuticas. IP: Josep Roma Castanyer Colaboradores: Pablo Velasco Puyó, Anna Llort Sales Entidad financiadora: Instituto de Salud Carlos III Financiación: 116765 Referencia: PI14/00647 Duración: 01/01/2015 - 31/12/2017 Paginación Página actual 1 Página 2 Siguiente página › Última página »
